The global tissue diagnostics market size reached US$ 4.8 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 7.2 Billion by 2027, exhibiting a CAGR of 6.99% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.
Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.
Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.
Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product type, technology, disease and end-user.Breakup by Product Type:
- Instruments
- Consumables
Breakup by Technology:
- Immunohistochemistry
- In Situ Hybridization
- Digital Pathology and Workflow Management
- Special Staining
Breakup by Disease:
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer
- Others
Breakup by End-User:
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etcKey Questions Answered in This Report:
- How has the global tissue diagnostics market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global tissue diagnostics industry?
- What has been the impact of COVID-19 on the global tissue diagnostics industry?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the disease?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global tissue diagnostics industry?
- What are the key driving factors and challenges in the global tissue diagnostics industry?
- What is the structure of the global tissue diagnostics industry and who are the key players?
- What is the degree of competition in the global tissue diagnostics industry?
- What are the profit margins in the global tissue diagnostics industry?
Frequently Asked Questions about the Global Tissue Diagnostics Market
What is the estimated value of the Global Tissue Diagnostics Market?
What is the growth rate of the Global Tissue Diagnostics Market?
What is the forecasted size of the Global Tissue Diagnostics Market?
Who are the key companies in the Global Tissue Diagnostics Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 108 |
| Published | September 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD
| USD 4.8 Billion |
| Forecasted Market Value ( USD
| USD 7.2 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Tissue Diagnostics Market
6 Market Breakup by Product Type
7 Market Breakup by Technology
8 Market Breakup by Disease
9 Market Breakup by End-User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Roche
- Danaher
- Thermo Fisher Scientific
- Abbott
- Agilent Technologies
- Merck
- Sakura Finetek Japan
- Abcam
- BD
- Qiagen
- Bio SB
- Biogenex
- Cell Signaling Technology
Methodology
LOADING...
